ArticleFrontiers in oncology2026

Marked response to dabrafenib plus trametinib in a patient with BRAF V600E-mutant pancreatic hepatoid carcinoma: a case report and systematic analysis of 57 cases.

Yingli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.